Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1-12, doi:10.1016/j.jacc.2008.03.036
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langer, H. F.
Right arrow Articles by Gawaz, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Langer, H. F.
Right arrow Articles by Gawaz, M.

Radionuclide Imaging

A Molecular Key to the Atherosclerotic Plaque

Harald F. Langer, MD*,*, Roland Haubner, PhD{dagger}, Bernd J. Pichler, PhD{ddagger} and Meinrad Gawaz, MD*

* Medizinische Klinik III, Eberhard Karls Universität Tübingen, Tübingen, Germany
{dagger} Universitätsklinik für Nuklearmedizin, Medizinische Universität Innsbruck, Innsbruck, Austria
{ddagger} Laboratory for Preclinical Imaging and Imaging Technology, Clinic of Radiology, University of Tübingen, Tübingen, Germany.


Figure 1
View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Major Criteria Defining the "Vulnerable Plaque"

Vulnerable atherosclerotic plaques are characterized by distinct attributes regarding morphology, stenosis, inflammation, thrombogenicity, injury, and enhanced proteinase activity.

 

Figure 2
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Molecular Principles to Detect Vulnerable Atherosclerotic Plaques

Based upon the increasing molecular knowledge regarding atherogenesis, different principles have been successfully used to image atherosclerotic plaques. One major complex is the molecular imaging of inflammation, which includes enhanced metabolic activity, chemotaxis, cell recruitment, and lipoprotein accumulation. Furthermore, mediators of angiogenesis, apoptosis, and matrix metalloproteinase (MMP) activity have been successfully applied. Another promising approach to detect vulnerable atherosclerotic plaque is the visualization of plaque thrombogenicity, including thrombosis and exposure of thrombogenic subendothelial matrix proteins. ECM = extracellular matrix; FCH = fluorocholine; FDG = fluorodeoxyglucose; GP = glycoprotein; LDL = low-density lipoprotein; L19 = antibody against the extra-domain B of fibronectin; MCP = monocyte chemoattractant protein; MDA2 = malondialdehyde epitope on oxidized low-density lipoprotein; ox-LDL = oxidized low-density lipoprotein; RGD = protein sequence "arginine-glycine-aspartic acid."

 

Figure 3
View larger version (103K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Detection of Neoangiogenesis

(Top) (A) Coronal image section from a 18F-Galacto-RGD positron emission tomography of a patient with a malignant melanoma and a lymph node metastasis at the right axilla obtained 60 min after tracer injection. The image shows a clearly contrasting tumor and rapid predominately renal elimination with low background activity in almost all areas of the body. (B and C) Patient with a soft tissue sarcoma dorsal of the right knee joint. (B) The image fusion of the 18F-Galacto-RGD positron emission tomography and the corresponding computed tomography scan shows that the regions of intense tracer uptake correspond with the enhancing tumor wall, whereas the nonenhancing hypodense center shows no tracer uptake. (C) Immunohistochemistry of a peripheral tumor section using the anti-{alpha}vβ3 monoclonal antibody LM609 demonstrates intense staining predominantly of tumor vasculature. (Bottom) (D) Immunohistochemical staining of tumor sections using the anti-{alpha}vβ3 mAb LM609 demonstrates that the squamous cell carcinoma of human origin do not express the {alpha}vβ3 integrin. (E) In contrast, staining of sections with an antibody against the murine β3-subunit indicates that the tumor vasculature is {alpha}vβ3-positive. (F and G) Transaxial images of nude mice bearing a human squamous cell carcinoma at the right shoulder acquired 90 min after 18F-Galacto-RGD injection show a clearly contrasting tumor. The signal reflects tracer accumulation due to {alpha}vβ3 expression exclusively in the tumor vasculature. Tracer accumulation can be blocked by injecting 18-mg cyclo(-Arg-Gly-Asp-DPhe-Val-) per kilogram mouse 10 min before tracer injection indicates receptor-specific accumulation. Adapted from Haubner et al. (43).

 

Figure 4
View larger version (40K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Detection of Atherosclerotic Plaques by Radiolabeled CD68-Fc

(A) (Oxidized) lipoproteins initiate and sustain the inflammation process in atherosclerotic lesions and are essential for foam cell generation. Scavenger receptors mediate the uptake of lipoproteins into macrophages and, thus, contribute substantially to foam cell formation. (B) A soluble dimeric form of the scavenger receptor CD68 conjugated to an Fc-fragment was radiolabeled with 124I and used to detect atherosclerosis in vivo. (C) Apolipoprotein E –/– (ApoE–/–) or wild type mice were fed a high cholesterol diet for 17 weeks. Subsequently, mice were injected intravenously with 124ICD68-Fc and sacrificed after 48 h. Ex-vivo nuclear imaging was performed to evaluate tracer activity in the aortic arch. Activity of 124ICD68-FC was enhanced in ApoE–/– compared with wild type mice (bottom) and correlated well with plaque extension as shown by sudan red staining in the aortic arch specimen (top). LDL = low-density lipoprotein.

 

Figure 5
View larger version (53K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Detection of Vulnerable, Thrombogenic Plaques by Radiolabeled Platelet GPVI

(A) Pathophysiology of platelet adhesion, secretion, and thrombus formation at sites of injured vascular endothelium with exposed extracellular matrix. 1) Within the intact vessel, platelets do not adhere to the endothelial monolayer under physiological conditions. 2) At site of atherosclerotic lesions, subendothelial proteins such as von Willebrand factor (vWF) and collagen are exposed to blood flow. Platelet adhesion receptors glycoprotein Ib (GPIb) and glycoprotein VI (GPVI) mediate tethering of platelets. 3) After activation of the integrins {alpha}2β1 (collagen receptor) and {alpha}IIbβ3 (fibrinogen receptor), platelets firmly adhere via interaction of these receptors with extracellular matrix proteins. 4) Subsequently, platelets get activated and secrete distinct mediators resulting in: 5) platelet aggregation via fibrinogen bridges between 2 {alpha}IIbβ3 receptors and thrombus formation. (B) A soluble dimeric form of human platelet GPVI conjugated to an Fc-fragment was used, which was radiolabeled with 124I. Glycoprotein VI is essential to establish the first interaction of platelets with an exposed collagen surface. Therefore, we made use of this natural mechanism to detect thrombogenic and, thus, vulnerable plaques. (C and D) Apolipoprotein E–/– mice were analyzed with 124IGPVI-Fc using an animal microPET scanner (MicroPET Focus 120, Siemens, Knoxville, Tennessee) (left). Images were acquired 24 h after administration of the tracer and imaging time was 20 min. Positron emission tomography (PET) images were correlated with computed tomographic (CT) data (right) to verify anatomical structures. (C) Shows transverse sections of these experiments. (D) Ex vivo nuclear imaging was performed to evaluate tracer activity in the aortic arch (top). The bottom shows the specimen after staining with sudan III. Activity of 124IGPVI-Fc correlated well with plaque extension (left). The signal could be nearly abolished, when nonlabeled GPVI-Fc was injected before application of 124IGPVI-Fc (right).

 

Figure 6
View larger version (62K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Molecular Imaging of Apoptosis in Atherosclerosis Using Radiolabeled Annexin

Technetium-99m labeled annexin A5 accumulates in unstable atherosclerotic plaques. (A) Single-photon emission computed tomography images of a patient with a recent transient ischemic attack. (B) Annexin A5 in sections of the resected plaque stains strongly in a macrophage-rich area. In contrast, a minimal annexin A5 signal (C) appears in the carotid artery of a patient with a transient ischemic attack 3 months before imaging. (D) Annexin A5 immunoreactivity is at a background level in the corresponding smooth-muscle-cell-rich lesion. Images provided courtesy of Dr. Bas Kietselaer and Dr. Leonard Hofstra, University Hospital of Maastricht, the Netherlands. Reprinted, with permission, from Kietselaer et al. (70).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement